Horn Howard 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Horn Howard
Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-01+19,400→ 99,766 total - Award
Stock Option (Right to Buy)
2024-03-01+34,200→ 34,200 totalExercise: $53.69Exp: 2034-03-01→ Common Stock (34,200 underlying)
Footnotes (3)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. The amount of securities beneficially owned in column 5 reflects the correction of a typographical error in the Form 4 filed by the Reporting Person on October 10, 2023 (the "October 2023 Form 4"). The accurate number of securities beneficially owned by the Reporting Person in Column 5 of the October 2023 Form 4 is 80,366.
- [F3]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.